Nantahala Capital Management, LLC Q2 2024 Filing

Filed August 14, 2024

Portfolio Value

$1.7B

Holdings

119

Report Date

Q2 2024

Filing Type

13F-HR

All Holdings (119 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	OKURRENEO PHARMACEUTICALS INC	547,804	$846K	0.05%
102	APREAPREA THERAPEUTICS INC	205,760	$837K	0.05%
103	8NI0NIKOLA CORP	99,999	$819K	0.05%
104	NMTCNEUROONE MED TECHNOLOGIES CO	950,962	$761K	0.04%
105	KRYSKRYSTAL BIOTECH INC	3,900	$716K	0.04%	Put
106	IMTXIMMATICS N.V	248,506	$688K	0.04%
107	GOSSGOSSAMER BIO INC	672,856	$623K	0.04%
108	RILYB. RILEY FINANCIAL INC	23,976	$423K	0.02%
109	EVOKEUREVOKE PHARMA INC	675,000	$357K	0.02%
110	LADRLADDER CAP CORP	25,631	$289K	0.02%
111	FBIOFORTRESS BIOTECH INC	153,152	$262K	0.02%
112	EWTXEDGEWISE THERAPEUTICS INC	13,371	$241K	0.01%
113	ANTXAN2 THERAPEUTICS INC	98,278	$211K	0.01%
114	—BM TECHNOLOGIES INC	76,034	$171K	0.01%
115	LLYELI LILLY & CO	160,000	$144K	0.01%	Put
116	XGNEXAGEN INC	59,316	$108K	0.01%
117	LUCDLUCID DIAGNOSTICS INC	126,362	$104K	0.01%
118	TACTTRANSACT TECHNOLOGIES INC	20,123	$76K	0.00%
119	APSGBPAPTOSE BIOSCIENCES INC	77,340	$59K	0.00%

PreviousPage 2 of 2